L
Lyka Labs
LYKALABS Share Price
Healthcare52.29
as on 13 Mar 2026 at 15:29
Market Cap
₹187 Cr
PE Ratio
-550.20
ROCE
10.34%
LYKALABS Fundamentals
Company Valuation
Market Cap (₹ Cr.)
187
PE Ratio
-550.20
PB Ratio
1.94
Dividend Yield
-
ROE
7.66%
ROCE
10.34%
Book Value (₹)
28.33
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 58.10% | 58.16% | 58.16% | 58.16% | 58.16% |
| Domestic Institutional Investors (DII) | 0.67% | 0.67% | 0.67% | 0.67% | 0.67% |
| Foreign Institutional Investors (FII) | 0.15% | 0.23% | 0.16% | 0.18% | 0.17% |
| Public Investors | 32.13% | 31.18% | 31.41% | 31.52% | 31.42% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
LYKALABS Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
500259
NSE Scrip Name
LYKALABS
ISIN
INE933A01014



